Center-Authored Papers

Filters: Author is Langston, Amelia A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KVI et al..  2013.  Antimicrobial prophylaxis and outpatient management of Fever and neutropenia in adults treated for malignancy: american society of clinical oncology clinical practice guideline.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(6):794-810. Abstract
G
Gyurkocza B, Storb R, Storer BE, Chauncey TR, Lange T, Shizuru JA, Langston AA, Pulsipher MA, Bredeson CN, Maziarz RT et al..  2010.  Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2859-67. Abstract
K
Kharfan-Dabaja MA, Boeckh MJ, Wilck MB, Langston AA, Chu AH, Wloch MK, Smith LR, Rolland AP, Kenney RT.  2013.  Reanalysis of TransVax immunogenicity.. The Lancet infectious diseases. 13(1):18.
Kharfan-Dabaja MA, Boeckh MJ, Wilck MB, Langston AA, Chu AH, Wloch MK, Guterwill DF, Smith LR, Rolland AP, Kenney RT.  2012.  A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.. The Lancet infectious diseases. 12(4):290-299. Abstract
Kornblit B, Maloney DG, Storer BE, Maris MB, Vindeløv L, Hari P, Langston AA, Pulsipher MA, Bethge WA, Chauncey TR et al..  2014.  A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after nonmyeloablative unrelated donor transplantation.. Haematologica. 99(10):1624-31. Abstract
R
Ram R, Storb R, Sandmaier BM, Maloney DG, Woolfrey AE, Flowers MED, Maris MB, Laport GG, Chauncey TR, Lange T et al..  2011.  Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.. Haematologica. 96(8):1113-20. Abstract
S
Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, Chauncey TR, Pulsipher MA, Petersen FB, Sahebi F et al..  2013.  Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(12):1530-8. Abstract
V
Vaughn JE, Sorror ML, Storer BE, Chauncey TR, Pulsipher MA, Maziarz RT, Maris MB, Hari P, Laport GG, Franke GN et al..  2015.  Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.. Cancer. 121(20):3709-3716. Abstract
Y
Young J-AH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER et al..  2015.  Infections following Transplantation of Bone Marrow or Peripheral-Blood Stem Cells from Unrelated Donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract